Freya Biosciences

Freya Biosciences is a clinical-stage immunology company that develops disease-modifying therapies to address inflammation and immune dysregulation in women. The company targets the underlying immunological drivers of conditions such as infertility, endometriosis, and dysbiosis during pregnancy to improve clinical outcomes. Its research focus includes restoring healthy biological function to reduce risks associated with preterm birth and IVF failure.